Induction of an HPV 6bL1-specific mucosal IgA response by DNA immunization

Vaccine

Volumn 19, Issue 2-3, 2000, Pages 227-233

  Schreckenberger, C ^a,b   Sethupathi, P ^a   Kanjanahaluethai, A ^a   Muller M ^a,c   Zhou, J ^a   Gissmann, L ^a,c   Qiao, L ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

DNA immunization; HPV; Mucosa

Indexed keywords

DNA VACCINE; IMMUNOGLOBULIN A ANTIBODY; PLASMID DNA; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS VACCINE; WART VIRUS VACCINE;

ANIMAL EXPERIMENT; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPROPHYLAXIS; INFECTION PREVENTION; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; RABBIT; TISSUE LEVEL; VAGINA MUCOSA; WART VIRUS;

EID: 0034666714     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00173-0     Document Type: Article

References (34)

1. Zur Hausen H. Viruses in human cancers. Science. 254:1991;1167-1173.
2. Zhou J., Sun X.Y., Stenzel D.J., Frazer I.H. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in eqithelial cells is sufficient for assembly of HPV virion-like particles. Virology. 185:(1):1991;251-257.
3. Lin Y.L., Borenstein L.A., Ahmed R., Wettstein F.O. Cottontail rabbit papillomavirus L1 protein-based vaccines: protection is achieved only with a full-length, nondenatured product. J. Virol. 678:1993;4154-4162.
4. Hagensee M.E., Olson N.H., Baker T.S., Galloway D.A. Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids. J. Virol. 68:1994;4503-4505.
5. Christensen N.D., Hopfl R., DiAngelo S.L., et al. Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titers of neutralizing antibodies. J. Gen. Virol. 75:1994;2271-2276.
6. Galloway D.A. Human papillomavirus vaccines: a warty problem. Infect. Agents Dis. 3:1994;87-193.
7. Liu X.S., Abdul-Jabbar I., Qi Y.M., Frazer I.H., Zhou J. Mucosal immunisation with papillomavirus-like particles elicits systemic and mucosal immunity in mice. Virology. 252:1998;39-45.
8. Chattergoon M., Boyer J., Weiner D.B. Genetic immunization: a new era in vaccines and immune therapeutics. FASEB J. 11:1997;753-763.
9. Robinson H.L., Torres C.A. DNA vaccines. Semin. Immunol. 9:1997;271-283.
10. Ulmer J.B., Sadoff J.C., Liu M.A. DNA vaccines. Curr. Opin. Immunol. 8:1996;531-536.
11. Hassett D.E., Whitton J.L. DNA immunization. Trends Microbiol. 4:1996;307-312.
12. Benton P.A., Kennedy R.C. DNA vaccines strategies for the treatment of cancer. Curr. Top Microbiol. Immunol. 226:1998;1-20.
13. Bagarazzi M.L., Boyer J.D., Ayyavoo V., Weiner D.B. Nucleic acid-based vaccines as an approach to immunization against human immunodeficiency virus type-1. Curr. Top Microbiol. Immunol. 226:1998;107-143.
14. Liew F.Y., Russell S.M., Appleyard G., Brand C.M., Beale J. Cross protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur. J. Immunol. 14:1984;350-356.
15. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C., Robinson H.L. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA. 90:1993;11478-11482.
16. Livingston J.B., Lu S., Robinson H., Anderson D.J. Immunization of the female genital tract with a DNA-based vaccine. Infect. Immun. 66:1998;322-329.
17. Ogra P.L., Ogra S.S. Local antibody response to polio vaccine in the human female genital tract. J. Immunol. 110:1973;1307-1311.
18. Ogra P.L., Yamanaka T., Losonsky G.A. Local immunogenic defenses in the genital tract. Gleicher N. Reproductive immunology. 1981;381-384 Alan R. Liss, New York.
19. Vaerman J.P., Ferin J. Local immunological response in the vagina, cervix and endometrium. Acta Endocrinol. Suppl. 194:1975;281-305.
20. Wang B., Ugen K.E., Srikantan V., et al. Gene inoculation generates immune responses against human immunodeficiency virus type-1. Proc. Natl. Acad. Sci. USA. 90:1993;4156-4160.
21. McLean C.S., Churcher M.J., Meinke J., et al. Production and characterization of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus. J. Clin. Pathol. 43:1990;488-492.
22. Roden R.B., Hubberty N.L., Kirnbauer R., Christensen N.D., Lowy D.R., Schiller J.T. Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition. J. Virol. 70:1996;3298-3301.
23. Christensen N.D., Kirnbauer R., Schiller J.T., et al. Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes. Virology. 205:1994;329-335.
24. Elson C.O., Dertzbaugh M.T. Mucosal adjuvants. Ogra P.L., Lamm M.E., McGhee J.R., Mestecky J., Strober W., Bienenstock J. Handbook of mucosal immunology. 1994;391 Academic press, San Diego.
25. Leclerc C., Ronco J. New approaches in vaccine development. Immunol. Today. 19:(7):1998;300-302.
26. Fontana M.R., Manetti R., Giannelli V., et al. Construction of nontoxic derivatives of cholera toxin and characterization of the immunological response against the A subunit. Infect. Immun. 63:1995;2356-2360.
27. Hagensee M.E., Carter J.J., Wipf G.C., Galloway D.A. Immunization of mice with HPV vaccinia virus recombinants generates serum IgG, IgM, and mucosal IgA anibodies. Virology. 206:1994;174-182.
28. Kuklin N., Daheshia M., Karem K., Manickan E., Rouse B.T. Induction of mucosal immunity against herpes simplex virus by plasmid immunization. J. Virol. 71:1997;3138-3145.
29. Sasaki S., Sumino K., Hamajima K., et al. Induction of systemic and mucosal immune responses to human immunodeficiency virus type-1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes. J. Virol. 72:1998;4931-4939.
30. Klavinskis L.S., Gao L.Q., Barnfield C., et al. Mucosal immunization with DNA-liposome complexes. Vaccine. 15:1997;818-820.
31. Buge S.L., Richardson E., Alipanah S., et al. An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge. J. Virol. 71:1997;8531-8541.
32. Donnelly J.J., Martinez D., Jansen K.U., Ellis R.W., Montgomery D.L., Liu M.A. Protection against papillomavirus with a polynucleotide vaccine. J. Infect. Dis. 713:1996;314-320.
33. Sundaram P., Tigelaar R.E., Brandsma J.L. Intracutaneous vaccination of rabbits with the cotton tail rabbit papillomavirus (CRPV) L1 gene protects against virus challenge. Vaccine. 15:1997;664-671.
34. Wang B., Dang K., Agadjanyan M.G., et al. Mucosal immunization with a DNA vaccine induces immune responses against HIV-1 at a mucosal site. Vaccine. 15:1997;821-825.